ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2022
Correction to: Value of PET imaging for radiation therapy.
Abstract readPublished Erratum
In one paragraph
Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023Article
Corrections and comments
- Erratum for
Authors and funding
39 authors.
Constantin LapaNuclear Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany.
Ursula NestleDepartment of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
Nathalie L AlbertDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Christian BauesDepartment of Radiation Oncology, Cyberknife and Radiotherapy, Medical Faculty, University Hospital Cologne, Cologne, Germany.
Ambros BeerDepartment of Nuclear Medicine, Ulm University Hospital, Ulm, Germany.
Andreas BuckDepartment of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
Volker BudachDepartment of Radiation Oncology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.
Rebecca BütofDepartment of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Stephanie E CombsGerman Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Thorsten DerlinDepartment of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Matthias EiberDepartment of Nuclear Medicine, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
Wolfgang P FendlerDepartment of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Christian FurthDepartment of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Cihan GaniGerman Cancer Consortium (DKTK), Partner Site Tübingen, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Eleni GkikaDepartment of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
Anca-L GrosuDepartment of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
Christoph HenkenberensDepartment of Radiotherapy and Special Oncology, Medical School Hannover, Hannover, Germany.
Harun IlhanDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Steffen LöckDepartment of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Simone Marnitz-SchulzeDepartment of Radiation Oncology, Cyberknife and Radiotherapy, Medical Faculty, University Hospital Cologne, Cologne, Germany.
Matthias MiedererDepartment of Nuclear Medicine, University Hospital Mainz, Mainz, Germany.
Michael MixDepartment of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Nils H NicolayDepartment of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
Maximilian NiyaziDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Christoph PöttgenDepartment of Radiation Oncology, West German Cancer Centre, University of Duisburg-Essen, Essen, Germany.
Claus M RödelGerman Cancer Consortium (DKTK), Partner Site Frankfurt, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Imke SchatkaDepartment of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Sarah M SchwarzenboeckDepartment of Nuclear Medicine, Rostock University Medical Centre, Rostock, Germany.
Andrei S TodicaDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Wolfgang WeberDepartment of Nuclear Medicine, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
Simone WegenDepartment of Radiation Oncology, Cyberknife and Radiotherapy, Medical Faculty, University Hospital Cologne, Cologne, Germany.
Thomas WiegelDepartment of Radiation Oncology, Ulm University Hospital, Ulm, Germany.
Constantinos ZamboglouDepartment of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
Daniel ZipsGerman Cancer Consortium (DKTK), Partner Site Tübingen, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Klaus ZöphelOncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
Sebastian ZschaeckDepartment of Radiation Oncology, Charité-Universitätsmedizin Berlin, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Daniela ThorwarthGerman Cancer Consortium (DKTK), Partner Site Tübingen, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Esther G C TroostDepartment of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. esther.troost@uniklinikum-dresden.de.ORCID http://orcid.org/0000-0001-9550-9050
Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
34617130What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.